M&T Bank’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $517K | Buy |
5,115
+441
| +9% | +$45.7K | ﹤0.01% | 1190 |
|
|
2026
Q1 | $452K | Sell |
4,674
-127
| -3% | -$13K | ﹤0.01% | 1153 |
|
|
2025
Q4 | $510K | Buy |
4,801
+2,832
| +144% | +$328K | ﹤0.01% | 1115 |
|
|
2025
Q3 | $250K | Sell |
1,969
-1,257
| -39% | -$150K | ﹤0.01% | 1290 |
|
|
2025
Q2 | $395K | Sell |
3,226
-48
| -1% | -$5.48K | ﹤0.01% | 1161 |
|
|
2025
Q1 | $332K | Sell |
3,274
-728
| -18% | -$71.1K | ﹤0.01% | 1229 |
|
|
2024
Q4 | $370K | Buy |
4,002
+92
| +2% | +$9.03K | ﹤0.01% | 1293 |
|
|
2024
Q3 | $378K | Buy |
3,910
+823
| +27% | +$74K | ﹤0.01% | 1267 |
|
|
2024
Q2 | $265K | Buy |
3,087
+73
| +2% | +$6.13K | ﹤0.01% | 1366 |
|
|
2024
Q1 | $248K | Hold |
3,014
| – | – | ﹤0.01% | 1414 |
|
|
2023
Q4 | $201K | Buy |
+3,014
| New | +$195K | ﹤0.01% | 1500 |
|
|
2022
Q3 | – | Sell |
-4,973
| Closed | -$216K | – | 1635 |
|
|
2022
Q2 | $216K | Sell |
4,973
-267
| -5% | -$13.7K | ﹤0.01% | 1346 |
|
|
2022
Q1 | $296K | Buy |
+5,240
| New | +$274K | ﹤0.01% | 1207 |
|
|
2021
Q4 | – | Sell |
-4,494
| Closed | -$268K | – | 1596 |
|
|
2021
Q3 | $268K | Hold |
4,494
| – | – | ﹤0.01% | 1286 |
|
|
2021
Q2 | $279K | Sell |
4,494
-2,450
| -35% | -$163K | ﹤0.01% | 1291 |
|
|
2021
Q1 | $451K | Sell |
6,944
-1,558
| -18% | -$102K | ﹤0.01% | 1048 |
|
|
2020
Q4 | $559K | Sell |
8,502
-3,382
| -28% | -$199K | ﹤0.01% | 991 |
|
|
2020
Q3 | $614K | Sell |
11,884
-1,209
| -9% | -$62K | ﹤0.01% | 882 |
|
|
2020
Q2 | $645K | Sell |
13,093
-396
| -3% | -$21.4K | ﹤0.01% | 840 |
|
|
2020
Q1 | $688K | Buy |
13,489
+818
| +6% | +$47.2K | ﹤0.01% | 794 |
|
|
2019
Q4 | $698K | Buy |
12,671
+2,449
| +24% | +$133K | ﹤0.01% | 743 |
|
|
2019
Q3 | $515K | Buy |
10,222
+930
| +10% | +$46.7K | ﹤0.01% | 952 |
|
|
2019
Q2 | $470K | Buy |
9,292
+2,194
| +31% | +$106K | ﹤0.01% | 1002 |
|
|
2019
Q1 | $330K | Buy |
7,098
+975
| +16% | +$49.4K | ﹤0.01% | 1160 |
|
|
2018
Q4 | $300K | Buy |
6,123
+786
| +15% | +$44.7K | ﹤0.01% | 1108 |
|
|
2018
Q3 | $331K | Buy |
5,337
+1,384
| +35% | +$84.2K | ﹤0.01% | 1189 |
|
|
2018
Q2 | $212K | Sell |
3,953
-2,937
| -43% | -$147K | ﹤0.01% | 1401 |
|
|
2018
Q1 | $313K | Sell |
6,890
-481
| -7% | -$20.6K | ﹤0.01% | 1197 |
|
|
2017
Q4 | $290K | Buy |
7,371
+1,381
| +23% | +$52.5K | ﹤0.01% | 1255 |
|
|
2017
Q3 | $221K | Buy |
+5,990
| New | +$213K | ﹤0.01% | 1372 |
|
|
2015
Q4 | – | Sell |
-14,185
| Closed | -$433K | – | 1773 |
|
|
2015
Q3 | $433K | Sell |
14,185
-14,184
| -50% | -$494K | ﹤0.01% | 1129 |
|
|
2015
Q2 | $1.04M | Buy |
28,369
+11,802
| +71% | +$421K | 0.01% | 884 |
|
|
2015
Q1 | $584K | Sell |
16,567
-346
| -2% | -$11.8K | ﹤0.01% | 1106 |
|
|
2014
Q4 | $517K | Sell |
16,913
-6,348
| -27% | -$198K | ﹤0.01% | 1185 |
|
|
2014
Q3 | $683K | Buy |
+23,261
| New | +$709K | ﹤0.01% | 1082 |
|
|
2014
Q2 | – | Sell |
-84
| Closed | -$2K | – | 1104 |
|
|
2014
Q1 | $2K | Buy |
+84
| New | +$2.19K | ﹤0.01% | 1120 |
|
Other funds holding EHC
M&T Bank's EHC Position: Q2 2026 in Review
M&T Bank increased its Encompass Health (EHC) stake by 9.4% in Q2 2026, buying an estimated $45.7K and bringing the position to 5,115 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #1190.
M&T Bank first reported a position in EHC in Q1 2014 and has held it in 36 quarters since. The position peaked at $1.04M in Q2 2015. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.
- M&T Bank held 5,115 shares of Encompass Health worth $517K as of Q2 2026.
- M&T Bank bought 441 Encompass Health shares in Q2 2026, an estimated $45.7K.
- Encompass Health made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1190 holding.
- M&T Bank first reported a position in Encompass Health in Q1 2014 and has held it in 36 quarters since.
- M&T Bank's Encompass Health position peaked at $1.04M in Q2 2015.
- 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.
Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.